On J, Endo USA, Inc. voluntarily recalled a single lot of Clonazepam 0.125 mg and 0.25 mg Orally Disintegrating tablets (ODT)
On J, Endo USA, Inc. recalled Clonazepam 0.125mg and 0.25mg Orally Disintegrating tablets (ODT) from a single lot due to a packaging
Endo – Expanded recall of clonazepam orally disintegrating tablets (ODT) disorder, with or without agoraphobia, as defined in DSM-V.
On J, Endo USA, Inc. recalled Clonazepam 0.125mg and 0.25mg Orally Disintegrating tablets (ODT) from a single lot due to a packaging error.
On J, Endo announced a consumer level recall of one lot of clonazepam 0.25 mg. ODT which may also appear as clonazepam 0.125 mg ODT.
On J. Endo announced a voluntary recall of one lot of clonazepam 0.25 mg orally disintegrating tablets (ODT) because they were packaged in
CLONAZEPAM ODT 0.125MG TABLETS. CLONAZEPAM ODT 0.25MG TABLETS. CLONAZEPAM ODT 0.5MG TABLETS. CLONAZEPAM ODT 1MG TABLETS. CLONAZEPAM ODT 2MG
Endo Recalls Clonazepam ODT Due to Carton Label Displaying Incorrect Strength. Diana Ernst, RPh
On J, Endo USA, Inc. voluntarily recalled a single lot of Clonazepam 0.125 mg and 0.25 mg Orally Disintegrating tablets (ODT)
Comments